Nexalin Technology, Inc. (NXL)Healthcare | Medical Devices | Houston, United States | NasdaqCM
0.40 USD
-0.06
(-13.718%) ⇩
(July 13, 2026, 4 p.m.
EDT)
After hours: 0.42 +0.02 (5.585%) ⇧ (July 13, 2026, 6:50 p.m. EDT) |
Hot Take ↕ | July 11, 2026, 5:21 a.m. EDT
The immediate outlook is deeply bearish as the stock has lost nearly 40% of its value over the last two weeks, trading well below its 50-day moving average despite a recent 4% pop on earnings guidance. This sharp decline reflects the market's rejection of the company's deteriorating fundamentals, specifically a massive 63.6% contraction in revenue and significant losses in both operating cash flow and free cash flow. While the management team is pushing hard on AI acquisitions and clinical trial results regarding psychiatric symptoms, these strategic moves cannot currently offset the bleeding balance sheet or the lack of profitability. There is no dividend to provide any cushion for income investors, and the negative earnings per share combined with a negative forward P/E suggests the business is not yet generating sustainable value. The statistical forecast model offers no directional bias, confirming that the short-term price action is likely driven by sentiment rather than a hidden catalyst. Until revenue growth turns positive and losses narrow, the risk-reward profile remains skewed heavily toward further downside. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.148086 |
| AutoARIMA | 0.152393 |
| AutoTheta | 0.154918 |
| AutoETS | 0.203448 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 35% |
| H-stat | 0.95 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.042 |
| Excess Kurtosis | -0.65 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 0.015 |
| Market Cap | 8,749,493 |
| Forward P/E | -1.28 |
| Beta | 4.03 |
| Website | https://www.nexalin.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.5524272 |
| Address1 | 1,776 Yorktown |
| Address2 | Suite 550 |
| All Time High | 4.49 |
| All Time Low | 0.253 |
| Ask | 0.5184 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 270,430 |
| Average Daily Volume3 Month | 610,349 |
| Average Volume | 610,349 |
| Average Volume10Days | 270,430 |
| Beta | 4.032 |
| Bid | 0.294 |
| Bid Size | 2 |
| Book Value | 0.14 |
| City | Houston |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.3975 |
| Current Ratio | 4.07 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 0.4245 |
| Day Low | 0.39 |
| Display Name | Nexalin Technology |
| Ebitda | -8,471,964 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.646 |
| Enterprise To Revenue | 19.859 |
| Enterprise Value | 5,472,719 |
| Eps Current Year | -0.38 |
| Eps Forward | -0.31 |
| Eps Trailing Twelve Months | -0.46 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.40754 |
| Fifty Day Average Change | -0.010039985 |
| Fifty Day Average Change Percent | -0.024635583 |
| Fifty Two Week Change Percent | -55.242718 |
| Fifty Two Week High | 2.0 |
| Fifty Two Week High Change | -1.6025 |
| Fifty Two Week High Change Percent | -0.80125 |
| Fifty Two Week Low | 0.305 |
| Fifty Two Week Low Change | 0.0925 |
| Fifty Two Week Low Change Percent | 0.30327868 |
| Fifty Two Week Range | 0.305 - 2.0 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,663,335,000,000 |
| Float Shares | 17,982,184 |
| Forward Eps | -0.31 |
| Forward P E | -1.282258 |
| Free Cashflow | -2,250,682 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 8 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.8199 |
| Gross Profits | 225,950 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.10501 |
| Held Percent Institutions | 0.048899997 |
| Implied Shares Outstanding | 22,011,302 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas. |
| Long Name | Nexalin Technology, Inc. |
| Market | us_market |
| Market Cap | 8,749,493 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_1763227626 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -8,330,681 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 9,923,782 |
| Number Of Analyst Opinions | 1 |
| Open | 0.42 |
| Operating Cashflow | -5,244,432 |
| Operating Margins | -141.79947 |
| Payout Ratio | 0.0 |
| Phone | 832 260 0222 |
| Post Market Change | 0.022199988 |
| Post Market Change Percent | 5.584903 |
| Post Market Price | 0.4197 |
| Post Market Time | 1,783,983,043 |
| Previous Close | 0.4607 |
| Price Eps Current Year | -1.0460527 |
| Price Hint | 4 |
| Price To Book | 2.8392859 |
| Price To Sales Trailing12 Months | 31.749146 |
| Profit Margins | 0.0 |
| Quick Ratio | 3.404 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.0632 |
| Regular Market Change Percent | -13.718253 |
| Regular Market Day High | 0.4245 |
| Regular Market Day Low | 0.39 |
| Regular Market Day Range | 0.39 - 0.4245 |
| Regular Market Open | 0.42 |
| Regular Market Previous Close | 0.4607 |
| Regular Market Price | 0.3975 |
| Regular Market Time | 1,783,972,800 |
| Regular Market Volume | 449,598 |
| Return On Assets | -1.61105 |
| Return On Equity | -3.19695 |
| Revenue Growth | -0.636 |
| Revenue Per Share | 0.015 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 22,011,302 |
| Shares Percent Shares Out | 0.0251 |
| Shares Short | 540,632 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 1,180,877 |
| Short Name | Nexalin Technology, Inc. |
| Short Percent Of Float | 0.026500002 |
| Short Ratio | 2.07 |
| Source Interval | 15 |
| State | TX |
| Symbol | NXL |
| Target High Price | 2.0 |
| Target Low Price | 2.0 |
| Target Mean Price | 2.0 |
| Target Median Price | 2.0 |
| Total Cash | 2,708,485 |
| Total Cash Per Share | 0.132 |
| Total Debt | 0 |
| Total Revenue | 275,582 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.46 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 0.688515 |
| Two Hundred Day Average Change | -0.291015 |
| Two Hundred Day Average Change Percent | -0.4226705 |
| Type Disp | Equity |
| Volume | 449,598 |
| Website | https://www.nexalin.com |
| Zip | 77,056 |